Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003748242 | SCV004559168 | pathogenic | Jeune thoracic dystrophy | 2023-09-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 446597). This premature translational stop signal has been observed in individual(s) with short-rib polydactyly syndrome (PMID: 29068549). This variant is present in population databases (rs766816050, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Asp4163Lysfs*45) in the DYNC2H1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). |
Fulgent Genetics, |
RCV001291282 | SCV005680497 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Dan Cohn Lab, |
RCV001291282 | SCV000611997 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291282 | SCV001479731 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | no assertion criteria provided | research | ||
Prevention |
RCV004742474 | SCV005363905 | pathogenic | DYNC2H1-related disorder | 2024-09-20 | no assertion criteria provided | clinical testing | The DYNC2H1 c.12487_12490delGATA variant is predicted to result in a frameshift and premature protein termination (p.Asp4163Lysfs*45). This variant along with a second variant in this gene has been reported in an individual with short rib-polydactyly syndrome ( Table S2, Zhang et al 2018. PubMed ID: 29068549). This variant is reported in 0.00089% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in DYNC2H1 are expected to be pathogenic. This variant is interpreted as pathogenic. |